Dominick M Lamonica
Overview
Explore the profile of Dominick M Lamonica including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
631
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sinha P, Lamonica D
AJR Am J Roentgenol
. 2023 Jan;
221(2):281.
PMID: 36629305
No abstract available.
2.
Haddad R, Bischoff L, Ball D, Bernet V, Blomain E, Busaidy N, et al.
J Natl Compr Canc Netw
. 2022 Aug;
20(8):925-951.
PMID: 35948029
Differentiated thyroid carcinomas is associated with an excellent prognosis. The treatment of choice for differentiated thyroid carcinoma is surgery, followed by radioactive iodine ablation (iodine-131) in select patients and thyroxine...
3.
Haddad R, Nasr C, Bischoff L, Busaidy N, Byrd D, Callender G, et al.
J Natl Compr Canc Netw
. 2018 Dec;
16(12):1429-1440.
PMID: 30545990
The NCCN Guidelines for Thyroid Carcinoma provide recommendations for the management of different types of thyroid carcinoma, including papillary, follicular, Hürthle cell, medullary, and anaplastic carcinomas. These NCCN Guidelines Insights...
4.
Haddad R, Lydiatt W, Ball D, Busaidy N, Byrd D, Callender G, et al.
J Natl Compr Canc Netw
. 2015 Sep;
13(9):1140-50.
PMID: 26358798
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were made to the systemic therapy recommendations for...
5.
Tuttle R, Haddad R, Ball D, Byrd D, Dickson P, Duh Q, et al.
J Natl Compr Canc Netw
. 2014 Dec;
12(12):1671-80.
PMID: 25505208
These NCCN Guidelines Insights focus on some of the major updates to the 2014 NCCN Guidelines for Thyroid Carcinoma. Kinase inhibitor therapy may be used to treat thyroid carcinoma that...
6.
Tuttle R, Ball D, Byrd D, Dilawari R, Doherty G, Duh Q, et al.
J Natl Compr Canc Netw
. 2010 Nov;
8(11):1228-74.
PMID: 21081783
No abstract available.
7.
Tuttle R, Ball D, Byrd D, Daniels G, Dilawari R, Doherty G, et al.
J Natl Compr Canc Netw
. 2010 May;
8(5):512-30.
PMID: 20495082
No abstract available.
8.
Sherman S, Angelos P, Ball D, Byrd D, Clark O, Daniels G, et al.
J Natl Compr Canc Netw
. 2007 Jul;
5(6):568-621.
PMID: 17623612
No abstract available.
9.
Klippenstein D, Lamonica D
Surg Oncol Clin N Am
. 2007 Jul;
16(3):471-92, vii.
PMID: 17606189
For most solid neoplasms, medical imaging is a vital component of tumor staging and surveillance. Imaging strategies vary according to the type and grade of primary neoplasm, tumor stage at...
10.
Sherman S, Angelos P, Ball D, Beenken S, Byrd D, Clark O, et al.
J Natl Compr Canc Netw
. 2005 Jul;
3(3):404-57.
PMID: 16002006
No abstract available.